Table 4

The power value of SNPs with VKH syndrome

ChrSNPAlleleStageMAF (Case/control)ORPower
1rs77258390AChinese Singaporean18.8/3.75.90.94
rs3762318C20.3/4.85.00.93
rs78597810C18.8/3.75.90.94
rs12568393A18.8/3.75.90.94
rs12561798C18.8/3.75.90.94
rs76436269A18.8/3.75.90.94
rs78377598T18.8/5.34.10.85
rs117633859G21.7/5.94.40.92
rs1884444G43.8/30.31.70.42
10rs10995276AThai34.6/18.22.30.67
rs442309T17.9/7.62.60.53
rs224048T34.6/18.22.30.67
rs224052A34.6/18.22.30.67
rs224057A34.6/18.22.30.67
rs224058T34.6/18.22.30.67
rs10995307C32.7/25.81.40.18
  • Power: we examined the power calculation using the Quanto program and assumed that the prevalence of VKH syndrome in Asian population is 0.001% according to the literature.

  • MAF, frequency of minor allele; SNP, single nucleotide polymorphism; VKH, Vogt–Koyanagi–Harada.